Orient Europharma Co

Orient Europharma Co Current Assets

The Current Assets of Orient Europharma Co (4120.TWO) as of Oct 21, 2026 is 1.15 B TWD. In the previous year, Current Assets was 1.95 B TWD — a change of -41.05% (lower).

Current Assets

1.15 BTWD

YoY

-41.05%

Last updated:

Current Assets of Orient Europharma Co is 2025 1.15 B TWD. Current Assets of Orient Europharma Co was 2024 1.95 B TWD. It decreases by -41.05% lower compared to the previous year.

The Orient Europharma Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
1.91 B TWD
Jan 1, 2019
2.21 B TWD
Jan 1, 2020
1.91 B TWD
Jan 1, 2021
1.75 B TWD
Jan 1, 2022
2.15 B TWD
Jan 1, 2023
1.97 B TWD
Jan 1, 2024
1.95 B TWD
Jan 1, 2025
1.15 B TWD
The Orient Europharma Co Current Assets history
YEARCurrent AssetsYoY
1.15 BTWD-41.05%
1.95 BTWD-1.12%
1.97 BTWD-8.50%
2.15 BTWD+22.98%
1.75 BTWD-8.23%
1.91 BTWD-13.69%
2.21 BTWD+15.69%
1.91 BTWD+1.92%
1.87 BTWD+0.97%
1.85 BTWD+18.14%
1.57 BTWD-43.57%
2.78 BTWD-2.01%
2.84 BTWD+22.95%
2.31 BTWD-6.32%
2.46 BTWD+14.08%
2.16 BTWD+9.85%
1.97 BTWD-17.28%
2.38 BTWD+55.59%
1.53 BTWD+48.62%
1.03 BTWD+10.59%
929.86 MTWD+10.73%
839.74 MTWD+1.78%
825.09 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd manufactures and trades western medicine, health food, and cosmetics. The company operates in the nutritious healthcare products and medical cosmetic products segment, offering infant milk powders, nutritious products, and functional healthcare products. It also provides dermatological preparations, medical hair care series, organic skin care series, and medical make-up products. In the western drugs segment, the company supplies products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases, and asthma. The company's primary customers include consumers seeking healthcare solutions and beauty products. Its products are sold under the company's own brand, targeting health-conscious individuals and those requiring medical-grade skincare and pharmaceuticals. The firm's segments focus on delivering specialized products for specific health conditions and cosmetic needs. Orient Europharma Co Ltd generates revenue through the sale of its manufactured and traded products across multiple segments. The nutritious healthcare products segment contributes to sales of infant milk powders and functional healthcare items, while the medical cosmetic products segment drives sales of dermatological and organic skincare lines. The western drugs segment supports revenue through pharmaceuticals for chronic and acute medical conditions. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

Current Assets of Orient Europharma Co is 1.15 B TWD in 2025.

Current Assets of Orient Europharma Co changed from 1.95 B TWD to 1.15 B TWD, representing a -41.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Orient Europharma Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Orient Europharma Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Orient Europharma Co